EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Unused potential of lipid-lowering therapy in very high-risk patients with atherosclerotic cardiovascular disease. A retrospective data analysis

Sarah B Pohl, Christiane Engelbertz, Holger Reinecke, Nasser M Malyar, Matthias Meyborg, Tobias J Brix, Julian Varghese, Katrin Gebauer

Nutrition, Metabolism and Cardiovascular Diseases · 2024

DOI: 10.1016/j.numecd.2024.03.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2024. Verfasst von Sarah B Pohl und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Cardiol, 48149 Muenster, Germany. Hauptthemen laut MEDLINE: Dyslipidemias, Biomarkers, Cholesterol, LDL, Atherosclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyslipidemiasBiomarkersCholesterol, LDLAtherosclerosisHumansMaleFemaleRetrospective StudiesAgedMiddle AgedRisk AssessmentTreatment OutcomeTime FactorsHydroxymethylglutaryl-CoA Reductase InhibitorsHeart Disease Risk FactorsPatient DischargePatient AdmissionRisk Reduction BehaviorPCSK9 InhibitorsRisk FactorsHypolipidemic AgentsAged, 80 and overPractice Patterns, Physicians'Proprotein Convertase 9

Stichwörter der Autor:innen

CholesterolEzetimibeHypercholesterolemiaLipid-lowering therapySecondary preventionStatin

Substanzen

BiomarkersCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsPCSK9 InhibitorsHypolipidemic AgentsPCSK9 protein, humanProprotein Convertase 9

Autor:innen und Institutionen

  • Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Cardiol, 48149 Muenster, Germany.
  • Institute of Medical Informatics, University of Muenster, 48149 Muenster, Germany.
  • Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Cardiol, 48149 Muenster, Germany. Electronic address: Katrin.Gebauer@ukmuenster.de.

Zitieren

APA

Pohl, S. B., Engelbertz, C., Reinecke, H., Malyar, N. M., Meyborg, M., Brix, T. J., Varghese, J., & Gebauer, K. (2024). Unused potential of lipid-lowering therapy in very high-risk patients with atherosclerotic cardiovascular disease. A retrospective data analysis. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2024.03.007

Vancouver

Pohl SB, Engelbertz C, Reinecke H, Malyar NM, Meyborg M, Brix TJ, et al. Unused potential of lipid-lowering therapy in very high-risk patients with atherosclerotic cardiovascular disease. A retrospective data analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2024. doi:10.1016/j.numecd.2024.03.007

BibTeX
@article{Pohl2024,
  author = {Pohl, Sarah B and Engelbertz, Christiane and Reinecke, Holger and Malyar, Nasser M and Meyborg, Matthias and Brix, Tobias J and Varghese, Julian and Gebauer, Katrin},
  title = {Unused potential of lipid-lowering therapy in very high-risk patients with atherosclerotic cardiovascular disease. A retrospective data analysis},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2024},
  doi = {10.1016/j.numecd.2024.03.007}
}
Kostenlos starten →